APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oncology Treatment Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oncology Treatment Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026196 pages

Choose your research edition.

Industry ResearchOncology Treatment Drug Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Oncology Treatment Drug Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Oncology Treatment Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oncology Treatment Drug Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Oncology Treatment Drug Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Oncology Treatment Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Oncology Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oncology Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oncology Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oncology Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oncology Treatment Drug include Takeda, Eisai, Teva, Sanofi, Johnson & Johnson, Novartis, Merck KGaA, Roche and Eli Lilly, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Oncology Treatment Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oncology Treatment Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oncology Treatment Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Oncology Treatment Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Oncology Treatment Drug Segment by Company

Takeda

Eisai

Teva

Sanofi

Johnson & Johnson

Novartis

Merck KGaA

Roche

Eli Lilly

Pfizer

Bayer

Amgen

AbbVie

AstraZeneca

Otsuka

Merck & Co.

Ipsen

Gilead Sciences

Celgene

Bristol-Myers Squibb

Biogen Idec

Astellas

Oncology Treatment Drug Segment by Type

Immunotherapy (Biologic Therapy)

Chemotherapy

Hormonal Therapy

Targeted Therapy

Others

Oncology Treatment Drug Segment by Application

Respiratory/Lung Cancer

Prostate Cancer

Breast Cancer

Gastrointestinal Cancer

Blood Cancer

Others

Oncology Treatment Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncology Treatment Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oncology Treatment Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncology Treatment Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Oncology Treatment Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oncology Treatment Drug industry.

Chapter 3: Detailed analysis of Oncology Treatment Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oncology Treatment Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oncology Treatment Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Immunotherapy (Biologic Therapy) Table 3. Key Players of Chemotherapy Table 4. Key Players of Hormonal Therapy Table 3. Key Players of Targeted Therapy Table 4. Key Players of Others Table 5. Global Oncology Treatment Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Respiratory/Lung Cancer Table 7. Key Players of Prostate Cancer Table 8. Key Players of Breast Cancer Table 9. Key Players of Gastrointestinal Cancer Table 10. Key Players of Blood Cancer Table 11. Key Players of Others Table 12. Global Oncology Treatment Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Oncology Treatment Drug Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Oncology Treatment Drug Market Share by Region (2021-2026) Table 15. Global Oncology Treatment Drug Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Oncology Treatment Drug Market Share by Region (2027-2032) Table 17. Oncology Treatment Drug Industry Trends Table 18. Oncology Treatment Drug Industry Drivers Table 19. Oncology Treatment Drug Industry Opportunities and Challenges Table 20. Oncology Treatment Drug Industry Restraints Table 21. Global Oncology Treatment Drug Revenue by Company (US$ Million) & (2021-2026) Table 22. Global Oncology Treatment Drug Revenue Market Share by Company (2021-2026) Table 23. Global Oncology Treatment Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 24. Global Oncology Treatment Drug Key Company Head Office and Area Served Table 25. Global Oncology Treatment Drug Company, Product Type & Application Table 26. Global Oncology Treatment Drug Company Establishment Date Table 27. Global Company Market Concentration Ratio (CR5 and HHI) Table 28. Global Oncology Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 29. Global Oncology Treatment Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Oncology Treatment Drug Market Size by Type (2021-2026) & (US$ Million) Table 31. Global Oncology Treatment Drug Market Size by Type (2027-2032) & (US$ Million) Table 32. Global Oncology Treatment Drug Revenue Market Share by Type (2021-2026) Table 33. Global Oncology Treatment Drug Revenue Market Share by Type (2027-2032) Table 34. Global Oncology Treatment Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Oncology Treatment Drug Market Size by Application (2021-2026) & (US$ Million) Table 36. Global Oncology Treatment Drug Market Size by Application (2027-2032) & (US$ Million) Table 37. Global Oncology Treatment Drug Revenue Market Share by Application (2021-2026) Table 38. Global Oncology Treatment Drug Revenue Market Share by Application (2027-2032) Table 39. Takeda Company Information Table 40. Takeda Business Overview Table 41. Takeda Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Takeda Oncology Treatment Drug Product Portfolio Table 43. Takeda Recent Development Table 44. Eisai Company Information Table 45. Eisai Business Overview Table 46. Eisai Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Eisai Oncology Treatment Drug Product Portfolio Table 48. Eisai Recent Development Table 49. Teva Company Information Table 50. Teva Business Overview Table 51. Teva Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Teva Oncology Treatment Drug Product Portfolio Table 53. Teva Recent Development Table 54. Sanofi Company Information Table 55. Sanofi Business Overview Table 56. Sanofi Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Sanofi Oncology Treatment Drug Product Portfolio Table 58. Sanofi Recent Development Table 59. Johnson & Johnson Company Information Table 60. Johnson & Johnson Business Overview Table 61. Johnson & Johnson Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Johnson & Johnson Oncology Treatment Drug Product Portfolio Table 63. Johnson & Johnson Recent Development Table 64. Novartis Company Information Table 65. Novartis Business Overview Table 66. Novartis Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Novartis Oncology Treatment Drug Product Portfolio Table 68. Novartis Recent Development Table 69. Merck KGaA Company Information Table 70. Merck KGaA Business Overview Table 71. Merck KGaA Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Merck KGaA Oncology Treatment Drug Product Portfolio Table 73. Merck KGaA Recent Development Table 74. Roche Company Information Table 75. Roche Business Overview Table 76. Roche Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Roche Oncology Treatment Drug Product Portfolio Table 78. Roche Recent Development Table 79. Eli Lilly Company Information Table 80. Eli Lilly Business Overview Table 81. Eli Lilly Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Eli Lilly Oncology Treatment Drug Product Portfolio Table 83. Eli Lilly Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Pfizer Oncology Treatment Drug Product Portfolio Table 88. Pfizer Recent Development Table 89. Bayer Company Information Table 90. Bayer Business Overview Table 91. Bayer Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Bayer Oncology Treatment Drug Product Portfolio Table 93. Bayer Recent Development Table 94. Amgen Company Information Table 95. Amgen Business Overview Table 96. Amgen Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Amgen Oncology Treatment Drug Product Portfolio Table 98. Amgen Recent Development Table 99. AbbVie Company Information Table 100. AbbVie Business Overview Table 101. AbbVie Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. AbbVie Oncology Treatment Drug Product Portfolio Table 103. AbbVie Recent Development Table 104. AstraZeneca Company Information Table 105. AstraZeneca Business Overview Table 106. AstraZeneca Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. AstraZeneca Oncology Treatment Drug Product Portfolio Table 108. AstraZeneca Recent Development Table 109. Otsuka Company Information Table 110. Otsuka Business Overview Table 111. Otsuka Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. Otsuka Oncology Treatment Drug Product Portfolio Table 113. Otsuka Recent Development Table 114. Merck & Co. Company Information Table 115. Merck & Co. Business Overview Table 116. Merck & Co. Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 117. Merck & Co. Oncology Treatment Drug Product Portfolio Table 118. Merck & Co. Recent Development Table 119. Ipsen Company Information Table 120. Ipsen Business Overview Table 121. Ipsen Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 122. Ipsen Oncology Treatment Drug Product Portfolio Table 123. Ipsen Recent Development Table 124. Gilead Sciences Company Information Table 125. Gilead Sciences Business Overview Table 126. Gilead Sciences Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 127. Gilead Sciences Oncology Treatment Drug Product Portfolio Table 128. Gilead Sciences Recent Development Table 129. Celgene Company Information Table 130. Celgene Business Overview Table 131. Celgene Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 132. Celgene Oncology Treatment Drug Product Portfolio Table 133. Celgene Recent Development Table 134. Bristol-Myers Squibb Company Information Table 135. Bristol-Myers Squibb Business Overview Table 136. Bristol-Myers Squibb Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 137. Bristol-Myers Squibb Oncology Treatment Drug Product Portfolio Table 138. Bristol-Myers Squibb Recent Development Table 139. Biogen Idec Company Information Table 140. Biogen Idec Business Overview Table 141. Biogen Idec Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 142. Biogen Idec Oncology Treatment Drug Product Portfolio Table 143. Biogen Idec Recent Development Table 144. Astellas Company Information Table 145. Astellas Business Overview Table 146. Astellas Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 147. Astellas Oncology Treatment Drug Product Portfolio Table 148. Astellas Recent Development Table 149. North America Oncology Treatment Drug Market Size by Type (2021-2026) & (US$ Million) Table 150. North America Oncology Treatment Drug Market Size by Type (2027-2032) & (US$ Million) Table 151. North America Oncology Treatment Drug Market Size by Application (2021-2026) & (US$ Million) Table 152. North America Oncology Treatment Drug Market Size by Application (2027-2032) & (US$ Million) Table 153. North America Oncology Treatment Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. North America Oncology Treatment Drug Market Size by Country (2021-2026) Table 155. North America Oncology Treatment Drug Market Size by Country (2027-2032) Table 156. Europe Oncology Treatment Drug Market Size by Type (2021-2026) & (US$ Million) Table 157. Europe Oncology Treatment Drug Market Size by Type (2027-2032) & (US$ Million) Table 158. Europe Oncology Treatment Drug Market Size by Application (2021-2026) & (US$ Million) Table 159. Europe Oncology Treatment Drug Market Size by Application (2027-2032) & (US$ Million) Table 160. Europe Oncology Treatment Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. Europe Oncology Treatment Drug Market Size by Country (2021-2026) Table 162. Europe Oncology Treatment Drug Market Size by Country (2027-2032) Table 163. China Oncology Treatment Drug Market Size by Type (2021-2026) & (US$ Million) Table 164. China Oncology Treatment Drug Market Size by Type (2027-2032) & (US$ Million) Table 165. China Oncology Treatment Drug Market Size by Application (2021-2026) & (US$ Million) Table 166. China Oncology Treatment Drug Market Size by Application (2027-2032) & (US$ Million) Table 167. Asia Oncology Treatment Drug Market Size by Type (2021-2026) & (US$ Million) Table 168. Asia Oncology Treatment Drug Market Size by Type (2027-2032) & (US$ Million) Table 169. Asia Oncology Treatment Drug Market Size by Application (2021-2026) & (US$ Million) Table 170. Asia Oncology Treatment Drug Market Size by Application (2027-2032) & (US$ Million) Table 171. Asia Oncology Treatment Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. Asia Oncology Treatment Drug Market Size by Country (2021-2026) Table 173. Asia Oncology Treatment Drug Market Size by Country (2027-2032) Table 174. South America, Middle East & Africa Oncology Treatment Drug Market Size by Type (2021-2026) & (US$ Million) Table 175. South America, Middle East & Africa Oncology Treatment Drug Market Size by Type (2027-2032) & (US$ Million) Table 176. South America, Middle East & Africa Oncology Treatment Drug Market Size by Application (2021-2026) & (US$ Million) Table 177. South America, Middle East & Africa Oncology Treatment Drug Market Size by Application (2027-2032) & (US$ Million) Table 178. South America, Middle East & Africa Oncology Treatment Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. South America, Middle East & Africa Oncology Treatment Drug Market Size by Country (2021-2026) Table 180. South America, Middle East & Africa Oncology Treatment Drug Market Size by Country (2027-2032) Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Oncology Treatment Drug Product Image Figure 2. Global Oncology Treatment Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Oncology Treatment Drug Market Share by Type: 2025 VS 2032 Figure 4. Immunotherapy (Biologic Therapy) Image Figure 5. Chemotherapy Image Figure 6. Hormonal Therapy Image Figure 7. Targeted Therapy Image Figure 8. Others Image Figure 9. Global Oncology Treatment Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Oncology Treatment Drug Market Share by Application: 2025 VS 2032 Figure 11. Respiratory/Lung Cancer Image Figure 12. Prostate Cancer Image Figure 13. Breast Cancer Image Figure 14. Gastrointestinal Cancer Image Figure 15. Blood Cancer Image Figure 16. Others Image Figure 17. Global Oncology Treatment Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 19. Global Oncology Treatment Drug Market Share by Region: 2025 VS 2032 Figure 20. Years Considered Figure 21. Global Oncology Treatment Drug Market Share by Players in 2025 Figure 22. Global Top 5 and 10 Oncology Treatment Drug Players Market Share by Revenue in 2025 Figure 23. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global Oncology Treatment Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Oncology Treatment Drug Revenue Market Share by Type (2021-2032) Figure 26. Global Oncology Treatment Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Oncology Treatment Drug Revenue Market Share by Application (2021-2032) Figure 28. North America Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 29. North America Oncology Treatment Drug Market Share by Type (2021-2032) Figure 30. North America Oncology Treatment Drug Market Share by Application (2021-2032) Figure 31. North America Oncology Treatment Drug Market Share by Country (2021-2032) Figure 32. United States Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 33. Canada Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 34. Mexico Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 35. Europe Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 36. Europe Oncology Treatment Drug Market Share by Type (2021-2032) Figure 37. Europe Oncology Treatment Drug Market Share by Application (2021-2032) Figure 38. Europe Oncology Treatment Drug Market Share by Country (2021-2032) Figure 39. Germany Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 40. France Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 41. U.K. Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 42. Italy Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 43. Russia Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 44. Nordic Countries Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 45. China Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 46. China Oncology Treatment Drug Market Share by Type (2021-2032) Figure 47. China Oncology Treatment Drug Market Share by Application (2021-2032) Figure 48. Asia Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 49. Asia Oncology Treatment Drug Market Share by Type (2021-2032) Figure 50. Asia Oncology Treatment Drug Market Share by Application (2021-2032) Figure 51. Asia Oncology Treatment Drug Market Share by Country (2021-2032) Figure 52. Japan Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 53. South Korea Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 54. Taiwan Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 55. Southeast Asia Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 56. India Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 57. Australia Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 59. South America, Middle East & Africa Oncology Treatment Drug Market Share by Type (2021-2032) Figure 60. South America, Middle East & Africa Oncology Treatment Drug Market Share by Application (2021-2032) Figure 61. South America, Middle East & Africa Oncology Treatment Drug Market Share by Country (2021-2032) Figure 62. Brazil Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 63. South Africa Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 64. Saudi Arabia Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 65. Turkey Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 66. Argentina Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 67. UAE Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 68. Egypt Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 69. Chile Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Immunotherapy (Biologic Therapy)
  • Chemotherapy
  • Hormonal Therapy
  • Targeted Therapy
  • Others
Applications
  • Respiratory/Lung Cancer
  • Prostate Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Blood Cancer
  • Others
Companies covered
  • Takeda
  • Eisai
  • Teva
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck KGaA
  • Roche
  • Eli Lilly
  • Pfizer
  • Bayer
  • Amgen
  • AbbVie
  • AstraZeneca
  • Otsuka
  • Merck & Co.
  • Ipsen
  • Gilead Sciences
  • Celgene
  • Bristol-Myers Squibb
  • Biogen Idec
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Oncology Treatment Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Immunotherapy (Biologic Therapy)
  5. 1.2.3 Chemotherapy
  6. 1.2.4 Hormonal Therapy
  7. 1.2.5 Targeted Therapy
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Oncology Treatment Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Respiratory/Lung Cancer
  12. 1.3.3 Prostate Cancer
  13. 1.3.4 Breast Cancer
  14. 1.3.5 Gastrointestinal Cancer
  15. 1.3.6 Blood Cancer
  16. 1.3.7 Others
  17. 1.4 Global Market Growth Prospects
  18. 1.5 Global Oncology Treatment Drug Growth Trends by Region
  19. 1.5.1 Global Oncology Treatment Drug Market Size by Region: 2021 VS 2025 VS 2032
  20. 1.5.2 Oncology Treatment Drug Market Size by Region (2021-2026)
  21. 1.5.3 Oncology Treatment Drug Market Size by Region (2027-2032)
  22. 1.6 Assumptions and Limitations
  23. 1.7 Study Goals and Objectives
  24. 1.8 Years Considered
2 Global Oncology Treatment Drug Market Dynamics
  1. 2.1 Oncology Treatment Drug Industry Trends
  2. 2.2 Oncology Treatment Drug Industry Drivers
  3. 2.3 Oncology Treatment Drug Industry Opportunities and Challenges
  4. 2.4 Oncology Treatment Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Oncology Treatment Drug Revenue by Company (2021-2026)
  2. 3.2 Global Oncology Treatment Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Oncology Treatment Drug Key Company Head office and Area Served
  4. 3.4 Global Oncology Treatment Drug Company, Product Type & Application
  5. 3.5 Global Oncology Treatment Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Oncology Treatment Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Oncology Treatment Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Oncology Treatment Drug Tier 1, Tier 2, and Tier 3
4 Oncology Treatment Drug Market by Type
  1. 4.1 Global Oncology Treatment Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Oncology Treatment Drug Market Size by Type (2021-2032)
  3. 4.3 Global Oncology Treatment Drug Market Size Share by Type (2021-2032)
5 Oncology Treatment Drug Market by Application
  1. 5.1 Global Oncology Treatment Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Oncology Treatment Drug Market Size by Application (2021-2032)
  3. 5.3 Global Oncology Treatment Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Takeda Oncology Treatment Drug Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Eisai
  8. 6.2.1 Eisai Company Information
  9. 6.2.2 Eisai Business Overview
  10. 6.2.3 Eisai Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Eisai Oncology Treatment Drug Product Portfolio
  12. 6.2.5 Eisai Recent Developments
  13. 6.3 Teva
  14. 6.3.1 Teva Company Information
  15. 6.3.2 Teva Business Overview
  16. 6.3.3 Teva Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Teva Oncology Treatment Drug Product Portfolio
  18. 6.3.5 Teva Recent Developments
  19. 6.4 Sanofi
  20. 6.4.1 Sanofi Company Information
  21. 6.4.2 Sanofi Business Overview
  22. 6.4.3 Sanofi Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Sanofi Oncology Treatment Drug Product Portfolio
  24. 6.4.5 Sanofi Recent Developments
  25. 6.5 Johnson & Johnson
  26. 6.5.1 Johnson & Johnson Company Information
  27. 6.5.2 Johnson & Johnson Business Overview
  28. 6.5.3 Johnson & Johnson Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Johnson & Johnson Oncology Treatment Drug Product Portfolio
  30. 6.5.5 Johnson & Johnson Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Novartis Oncology Treatment Drug Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Merck KGaA
  38. 6.7.1 Merck KGaA Company Information
  39. 6.7.2 Merck KGaA Business Overview
  40. 6.7.3 Merck KGaA Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Merck KGaA Oncology Treatment Drug Product Portfolio
  42. 6.7.5 Merck KGaA Recent Developments
  43. 6.8 Roche
  44. 6.8.1 Roche Company Information
  45. 6.8.2 Roche Business Overview
  46. 6.8.3 Roche Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Roche Oncology Treatment Drug Product Portfolio
  48. 6.8.5 Roche Recent Developments
  49. 6.9 Eli Lilly
  50. 6.9.1 Eli Lilly Company Information
  51. 6.9.2 Eli Lilly Business Overview
  52. 6.9.3 Eli Lilly Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Eli Lilly Oncology Treatment Drug Product Portfolio
  54. 6.9.5 Eli Lilly Recent Developments
  55. 6.10 Pfizer
  56. 6.10.1 Pfizer Company Information
  57. 6.10.2 Pfizer Business Overview
  58. 6.10.3 Pfizer Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Pfizer Oncology Treatment Drug Product Portfolio
  60. 6.10.5 Pfizer Recent Developments
  61. 6.11 Bayer
  62. 6.11.1 Bayer Company Information
  63. 6.11.2 Bayer Business Overview
  64. 6.11.3 Bayer Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Bayer Oncology Treatment Drug Product Portfolio
  66. 6.11.5 Bayer Recent Developments
  67. 6.12 Amgen
  68. 6.12.1 Amgen Company Information
  69. 6.12.2 Amgen Business Overview
  70. 6.12.3 Amgen Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Amgen Oncology Treatment Drug Product Portfolio
  72. 6.12.5 Amgen Recent Developments
  73. 6.13 AbbVie
  74. 6.13.1 AbbVie Company Information
  75. 6.13.2 AbbVie Business Overview
  76. 6.13.3 AbbVie Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 AbbVie Oncology Treatment Drug Product Portfolio
  78. 6.13.5 AbbVie Recent Developments
  79. 6.14 AstraZeneca
  80. 6.14.1 AstraZeneca Company Information
  81. 6.14.2 AstraZeneca Business Overview
  82. 6.14.3 AstraZeneca Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 AstraZeneca Oncology Treatment Drug Product Portfolio
  84. 6.14.5 AstraZeneca Recent Developments
  85. 6.15 Otsuka
  86. 6.15.1 Otsuka Company Information
  87. 6.15.2 Otsuka Business Overview
  88. 6.15.3 Otsuka Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Otsuka Oncology Treatment Drug Product Portfolio
  90. 6.15.5 Otsuka Recent Developments
  91. 6.16 Merck & Co.
  92. 6.16.1 Merck & Co. Company Information
  93. 6.16.2 Merck & Co. Business Overview
  94. 6.16.3 Merck & Co. Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Merck & Co. Oncology Treatment Drug Product Portfolio
  96. 6.16.5 Merck & Co. Recent Developments
  97. 6.17 Ipsen
  98. 6.17.1 Ipsen Company Information
  99. 6.17.2 Ipsen Business Overview
  100. 6.17.3 Ipsen Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Ipsen Oncology Treatment Drug Product Portfolio
  102. 6.17.5 Ipsen Recent Developments
  103. 6.18 Gilead Sciences
  104. 6.18.1 Gilead Sciences Company Information
  105. 6.18.2 Gilead Sciences Business Overview
  106. 6.18.3 Gilead Sciences Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Gilead Sciences Oncology Treatment Drug Product Portfolio
  108. 6.18.5 Gilead Sciences Recent Developments
  109. 6.19 Celgene
  110. 6.19.1 Celgene Company Information
  111. 6.19.2 Celgene Business Overview
  112. 6.19.3 Celgene Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Celgene Oncology Treatment Drug Product Portfolio
  114. 6.19.5 Celgene Recent Developments
  115. 6.20 Bristol-Myers Squibb
  116. 6.20.1 Bristol-Myers Squibb Company Information
  117. 6.20.2 Bristol-Myers Squibb Business Overview
  118. 6.20.3 Bristol-Myers Squibb Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Bristol-Myers Squibb Oncology Treatment Drug Product Portfolio
  120. 6.20.5 Bristol-Myers Squibb Recent Developments
  121. 6.21 Biogen Idec
  122. 6.21.1 Biogen Idec Company Information
  123. 6.21.2 Biogen Idec Business Overview
  124. 6.21.3 Biogen Idec Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Biogen Idec Oncology Treatment Drug Product Portfolio
  126. 6.21.5 Biogen Idec Recent Developments
  127. 6.22 Astellas
  128. 6.22.1 Astellas Company Information
  129. 6.22.2 Astellas Business Overview
  130. 6.22.3 Astellas Oncology Treatment Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 Astellas Oncology Treatment Drug Product Portfolio
  132. 6.22.5 Astellas Recent Developments
7 North America
  1. 7.1 North America Oncology Treatment Drug Market Size (2021-2032)
  2. 7.2 North America Oncology Treatment Drug Market Size by Type
  3. 7.2.1 North America Oncology Treatment Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Oncology Treatment Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Oncology Treatment Drug Market Share by Type (2021-2032)
  6. 7.3 North America Oncology Treatment Drug Market Size by Application
  7. 7.3.1 North America Oncology Treatment Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Oncology Treatment Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Oncology Treatment Drug Market Share by Application (2021-2032)
  10. 7.4 North America Oncology Treatment Drug Market Size by Country
  11. 7.4.1 North America Oncology Treatment Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Oncology Treatment Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Oncology Treatment Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Oncology Treatment Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Oncology Treatment Drug Market Size (2021-2032)
  2. 8.2 Europe Oncology Treatment Drug Market Size by Type
  3. 8.2.1 Europe Oncology Treatment Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Oncology Treatment Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Oncology Treatment Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Oncology Treatment Drug Market Size by Application
  7. 8.3.1 Europe Oncology Treatment Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Oncology Treatment Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Oncology Treatment Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Oncology Treatment Drug Market Size by Country
  11. 8.4.1 Europe Oncology Treatment Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Oncology Treatment Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Oncology Treatment Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Oncology Treatment Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Oncology Treatment Drug Market Size (2021-2032)
  2. 9.2 China Oncology Treatment Drug Market Size by Type
  3. 9.2.1 China Oncology Treatment Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Oncology Treatment Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Oncology Treatment Drug Market Share by Type (2021-2032)
  6. 9.3 China Oncology Treatment Drug Market Size by Application
  7. 9.3.1 China Oncology Treatment Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Oncology Treatment Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Oncology Treatment Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Oncology Treatment Drug Market Size (2021-2032)
  2. 10.2 Asia Oncology Treatment Drug Market Size by Type
  3. 10.2.1 Asia Oncology Treatment Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Oncology Treatment Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Oncology Treatment Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Oncology Treatment Drug Market Size by Application
  7. 10.3.1 Asia Oncology Treatment Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Oncology Treatment Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Oncology Treatment Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Oncology Treatment Drug Market Size by Country
  11. 10.4.1 Asia Oncology Treatment Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Oncology Treatment Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Oncology Treatment Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Oncology Treatment Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Oncology Treatment Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Oncology Treatment Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Oncology Treatment Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Oncology Treatment Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Oncology Treatment Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Oncology Treatment Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Oncology Treatment Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Oncology Treatment Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Oncology Treatment Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Oncology Treatment Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Oncology Treatment Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Oncology Treatment Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Oncology Treatment Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Oncology Treatment Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst